コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lphaq-protein-coupled receptor activation of protein kinase C.
2 lation by Pho85-Pho80, protein kinase A, and protein kinase C.
3 by parallel signaling via either calcium or protein kinase C.
4 dulin-dependent protein kinase kinase 2, and protein kinase C.
5 sed in host cells gamma134.5 targets p32 and protein kinase C.
6 ernalization, possibly through activation of protein kinase C.
7 osphorylation by protein kinase A but not by protein kinase C.
8 ns require the function of Ca(2+) -dependent protein kinase C.
9 rization that were reversed by inhibitors of protein kinase C, a downstream kinase in the protocadher
11 ly in part by spatially restricting atypical protein kinase C, a negative regulator of non-muscle myo
14 ations of diabetes and is caused by abnormal protein kinase C activation as a result of increased dia
15 rotein--tagged Rab proteins, pharmacological protein kinase C activation mimicked alpha1B-AR traffic
16 couple to Gq proteins, calcium signaling and protein kinase C activation; subsequently, the receptors
18 mbrane complexes and observed that different protein kinase C activators differentially position the
19 am-V or phorbol 12-myristate 13-acetate, two protein kinase C activators, leads to altered morphology
20 red actin rearrangement, tyrosine kinase and protein kinase C activities, and both clathrin and lipid
21 cortical actin depolymerization but affected protein kinase C activity and the 14-3-3e substrate.
22 cible mitochondrial function is dependent on protein kinase C activity, and is required to fine-tune
23 latter interaction was abrogated by blocking protein kinase C activity, resulting in receptor retenti
24 ts of G protein-coupled serotonin receptors, protein kinase C agonists, and a microbial metabolite no
25 y reversal by histone deactylase inhibitors, protein kinase C agonists, and proteasome inhibitors wit
27 erapy identified a crucial role for enhanced protein kinase c alpha (PKCalpha) signaling and downstre
28 traspanin membrane scaffold, CD82, regulates protein kinase c alpha (PKCalpha)-mediated signaling cri
29 d cell-to-cell contact and fusion, decreased protein kinase C alpha expression, and ultimately reduce
30 ses electrical and mechanical disruption via protein kinase C alpha/beta (PKCalpha/beta) activation.
32 ssion electron microscopy, and bipolar cell (protein kinase C-alpha [PKC-alpha] and recoverin) immuno
33 xpression, respectively, blocks and augments protein kinase C-alpha/nuclear factor of kappa light pol
34 We modified this structure by modulation of protein kinase C, an enzyme regulating neurite growth an
35 es for the design of simpler, more effective protein kinase C analogs and could also prove relevant t
37 pted such that additional kinases, including protein kinase C and c-Jun N-terminal kinase, contribute
40 n E2, PGE2-G, mobilizes Ca(2+) and activates protein kinase C and ERK, suggesting the involvement of
41 ical (vismodegib) and noncanonical (atypical protein kinase C and MRTF inhibitors) HH pathway inhibit
42 ell stage is directed by Phospholipase C and Protein kinase C and occurs in two phases: polarisation
44 occurs at least partly through inhibition of protein kinase C and receptor tyrosine kinase activity.
47 n shown in Xenopus oocytes to be affected by protein kinases C and A, we used different nonselective
48 s dependent on C5aR1, intracellular calcium, protein kinase C, and calmodulin, and downstream signali
50 echanism dependent on intracellular calcium, protein kinase C, and phosphatidylinositol 3-kinases-bas
51 phospholipase C pathways, including calcium, protein kinase C, and phosphoinositide 3-kinase but not
54 red for this response together with calcium, protein kinase C, and to some extent, phosphoinositide 3
55 A431 epithelial cells transduced Gbetagamma-protein kinase C- and Gbetagamma-metalloproteinase/EGFR-
56 f KV 1.5, but not KV 2.1, channels through a protein kinase C- and lysosome-dependent mechanism, redu
58 l cell polarity, with expression of atypical protein kinase C (aPKC) at the contact-free domain, nucl
59 of the PI3K signaling intermediate atypical protein kinase C (aPKC) constrains food intake, weight g
60 proteins PAR-3, PAR-6, CDC-42, and atypical protein kinase C (aPKC) form a core unit of the PAR prot
62 m diverse systems suggests that the atypical Protein Kinase C (aPKC) is a key regulator of cell fate
66 noid cultures, we show that the PAR-atypical protein kinase C (aPKC) polarity complex inhibits EMT an
68 lg) links the Par complex component atypical Protein Kinase C (aPKC) to the essential spindle orienta
70 apical Par complex, which contains atypical protein kinase C (aPKC), Bazooka (Par-3), and Par-6, is
71 and Dlg do not directly antagonize atypical protein kinase C (aPKC), but may instead restrict aPKC l
76 by counteracting the negative influences of protein kinase C beta (PKCbeta) via dephosphorylation an
77 duced phosphorylation of the kinases Lyn and protein kinase C-beta and MAPKs MKK-3/6 and p38MAPK or t
78 VCAM1) on MSCs, leading to the activation of protein kinase C beta1 (PKCbeta1) signaling and repressi
84 utative amplification module in which Ca(2+)-protein kinase C (Ca(2+)-PKC) is hypothesized to phospho
86 ecules crucial to PMA-induced NETs including protein kinase C, calcium, reactive oxygen species, the
87 G protein-coupled receptor kinase 6, whereas protein kinase-C can also contribute to agonist-induced
90 ecreased expression of the calcium-dependent protein kinase C conventional subclass alpha/beta leadin
91 We previously reported that conventional protein kinase C (cPKC) contributes to nuclear size redu
92 Ca(2+)- and diacylglycerol (DAG)-activated protein kinase C (cPKC) promotes learning and behavioral
94 osphorylation motifs targeted by the kinases protein kinase C, cyclin-dependent kinase, and mitogen-a
97 ence (false discovery rate < .10), including protein kinase C delta (PKCdelta), a CeL microcircuit ce
98 -CUB-domain containing protein 1 (CDCP1) and protein kinase C delta (PKCdelta)-in 56 formalin-fixed,
101 w here that ES-62-mediated downregulation of protein kinase C-delta (PKC-delta), a TLR4-associated si
103 ctivation of focal adhesion kinase 1 (FAK1), protein kinase C-delta (PRKCD), and Ephrin (EPH) family
106 have previously demonstrated that PKCdelta (protein kinase C-delta) regulates multiple components of
107 tion of neurons, marked by the expression of protein kinase C-delta, in the oval region of the bed nu
108 rated that phosphorylation of GAPDH by delta protein kinase C (deltaPKC) inhibits this GAPDH-dependen
109 nal approach to identify inhibitors of delta protein kinase C (deltaPKC), each inhibiting the phospho
113 cribe a mechanism by which Ang II stimulates protein kinase C-dependent KV 1.5 channel degradation, r
115 e AT1 R stimulates actin polymerization by a protein kinase C-dependent mechanism, but independently
116 s via separate information pathways and that protein kinase C-dependent mechanisms regulate translati
117 s study identifies a G protein-dependent and protein kinase C-dependent signaling pathway that dynami
119 oll-like receptor 4 (TLR4) and signaling via protein kinase C epsilon (PKCepsilon) in common, whereas
122 duced by agonists at receptors that activate protein kinase C epsilon (PKCepsilon), occurs in male bu
123 d to determine whether SIRT5 is activated by protein kinase C epsilon (PKCepsilon)-mediated increases
125 ycerol-mediated (DAG-mediated) activation of protein kinase C-epsilon (PKCepsilon) and the consequent
127 for ROS production, NADPH assembly capacity, protein kinase C expression, and calcium release in resp
128 (phospholipase C/inositol 1,4,5-triphosphate/protein kinase C/extracellular signal-regulated kinase)
129 ynia induced by inflammatory injuries, while protein kinase C gamma (PKCgamma) neurons at the lamina
130 ase M zeta (PKMzeta), an atypical isoform of protein kinase C, has been suggested to be necessary and
134 y dopamine in an ALK-dependent manner, and a protein kinase C inhibitor completely blocked dopamine-i
135 of which were suppressed by chelerythrine, a protein kinase C inhibitor, DPI, a NADPH-dependent oxida
136 leimide (BIM; a protein kinase C blocker), a protein kinase C inhibitory peptide or bafilomycin A (a
137 verexpression of the protein kinase atypical protein kinase C iota (aPKCi), an oncogene, triggers bas
139 catalase, and activation of the pro-oxidant protein kinase C isoform beta-II (PKCbetaII)-dependent p
140 th the viral capsid (Cap) protein to enhance protein kinase C isoform delta (PKC-delta) activity; thi
141 viral capsid (Cap) protein; simultaneously, protein kinase C isoform delta (PKC-delta) was phosphory
142 protein kinase Mzeta (PKMzeta), an atypical protein kinase C isoform that is thought to sustain memo
143 e Mzeta (PKMzeta), a brain-specific atypical protein kinase C isoform, is important for maintaining l
145 Sotrastaurin, a small molecule targeting protein kinase C isoforms, failed to provide adequate im
146 ncreased phosphorylation of stress activated protein kinase/c-Jun N-terminal kinase and that other de
147 ) all-atom molecular dynamics simulations of protein kinase C-ligand-membrane complexes and observed
148 n/LLGL1 interaction is inhibited by atypical protein kinase C-mediated phosphorylation of LLGL1, rest
149 we found that KCC2 recycling is enhanced by protein kinase C-mediated phosphorylation of the GluK2 C
150 bition of G (betagamma,) phospholipase C, or protein kinase C mimicked agonist removal, whereas activ
153 ng the activity of integrin-linked kinase or protein kinase C mu either by small interfering RNA-medi
154 e mechanistic insights revealed CXCR2-driven protein kinase C mu-dependent integrin-linked kinase to
155 e (ZIP), which was originally developed as a protein kinase C/Mzeta (PKCzeta/PKMzeta) inhibitor, is k
157 kemic cells, partly via Toll-like receptor-2/protein kinase C/nuclear factor-kappaB signaling, and po
158 how bryostatin interacts with membrane-bound protein kinase C, offering insights for the design of br
159 KF neurons was not enhanced by activation of protein kinase C or in slices from morphine-treated rats
160 synthase (eNOS) at Thr497 (eNOS(pThr497)) by protein kinase C or RhoA-activated kinase is a major reg
163 D300f receptor cytoplasmic tail inhibits the protein kinase C phosphorylation of a threonine and is a
164 drenergic receptors that had been mutated at protein kinase C phosphorylation sites (S396A, S402A) we
165 , well-known Cx43 Akt, protein kinase A, and protein kinase C phosphorylation sites located in the vi
166 gulated by endocytic trafficking, and direct protein kinase C (PKC) activation acutely diminishes DAT
167 mplex signalling pathway involving sustained protein kinase C (PKC) activation, inhibition of serine/
169 ial link between stress and hERG function is protein kinase C (PKC) activation; however, seemingly co
170 eported that human TRESK is activated by the protein kinase C (PKC) activator PMA (phorbol 12-myrista
171 in the PVN, whether endogenous AT1 receptor-protein kinase C (PKC) activity mediates the augmented N
172 ) activity was blocked with H89, or when the protein kinase C (PKC) activity was blocked with bisindo
173 Activation of TRPC1-based SOCs requires protein kinase C (PKC) activity, which is proposed to ph
174 Stimulation of TRPC1-based SOCs requires protein kinase C (PKC) activity, with store-operated PKC
177 on of MOR activates a Galpha(i/o)-Gbetagamma-protein kinase C (PKC) alpha phosphorylation pathway tha
178 DOPr endocytosis and endosomal signaling by protein kinase C (PKC) and extracellular signal-regulate
179 d and functionally localized the dynamics of protein kinase C (PKC) and extracellular signal-regulate
180 CR) signaling is regulated by members of the protein kinase C (PKC) and GPCR kinase (GRK) families, a
181 te our extensive knowledge on the biology of protein kinase C (PKC) and its involvement in disease, l
182 eat protein phosphatase 1 (Phlpp1) regulates protein kinase C (PKC) and other proteins in the control
183 actor (FGF) receptor, phospholipase C (PLC), protein kinase C (PKC) and phosphoinositide-3-kinase (PI
185 9 regulation include stimulation by Galphas, protein kinase C (PKC) betaII, or calcium-calmodulin kin
190 functions reveal unexpected features of the protein kinase C (PKC) family of serine/threonine protei
193 hospholipase Cgamma1 (PLCgamma1), Ca(2+), or protein kinase C (PKC) impair clathrin-mediated endocyto
194 RP) stimulated CLR endocytosis and activated protein kinase C (PKC) in the cytosol and extracellular
199 ere, we demonstrate that classical and novel protein kinase C (PKC) isoforms distinctly regulate card
201 are formed from calpain-mediated cleavage of protein kinase C (PKC) isoforms, each form of LTF is sen
202 effect, while inhibition of the conventional protein kinase C (PKC) isoforms, particularly PKCalpha,
204 Diacylglycerol (DAG)/phorbol ester-regulated protein kinase C (PKC) isozymes have been widely linked
206 as histone deacetylase (HDAC) inhibitors and protein kinase C (PKC) modulators, provides a promising
208 2)/inositol 1,4,5-trisphosphate (IP3)/Ca(2+)/protein kinase C (PKC) pathway significantly impaired th
211 gly repressed by inhibitors for PLCgamma1 or protein kinase C (PKC) pathways, while treatment with th
212 q)/phospholipase C (PLC)beta1 activities and protein kinase C (PKC) phosphorylation, although it is u
214 arance of CP-AMPARs and that AKAP79-anchored protein kinase C (PKC) primarily drives the appearance o
217 m, and identified a novel axis whereby WNT5a/protein kinase C (PKC) signaling regulates specific beta
218 kinase (ROCK) inhibition; however, augmented protein kinase C (PKC) signaling was found to contribute
219 reaction-diffusion model of phospholipase C/protein kinase C (PKC) signaling, which was recently ide
220 Cx43 with serine to alanine mutations at the protein kinase C (PKC) site Cx43(S368A), the casein kina
222 and hypothalamus, as being important in the protein kinase C (PKC) supported activity of the GG geno
224 ing mechanism, presynaptic calcium activates protein kinase C (PKC) to increase neurotransmitter rele
225 the requisite pharmacophores for binding to protein kinase C (PKC) together with a modified bryostat
226 to maintain affinity for bryostatin's target protein kinase C (PKC) while enabling exploration of the
227 act in a linear signaling cascade that, via protein kinase C (PKC), activates in parallel the MAP-ki
228 protein RAC family small GTPase 1 (RAC1) and protein kinase C (PKC), and a later arrestin-scaffolded
229 kinase II (CaMKII), protein kinase A (PKA), protein kinase C (PKC), and AMPA receptor genes that pla
230 rotein kinase M (PKM), the truncated form of protein kinase C (PKC), can maintain long-term changes i
231 l binds to the phorbol ester binding site of protein kinase C (PKC), induces translocation of PKC to
232 is regulated through its phosphorylation by protein kinase C (PKC), which plays multiple roles, incl
233 that mutant alpha-syn fails to complex with protein kinase C (PKC), which, in turn, results in impai
234 Growth-associated protein 43 (GAP43), a protein kinase C (PKC)-activated phosphoprotein, is ofte
235 exon (STREX) in the KCNMA1 gene, permitting protein kinase C (PKC)-dependent channel activation.
236 at muscle activity is associated with rapid, protein kinase C (PKC)-dependent ClC-1 Cl(-) channel inh
237 es suggest that PTP results primarily from a protein kinase C (PKC)-dependent increase in release pro
238 potentials (APs) is known to trigger rapid, protein kinase C (PKC)-dependent inhibition of ClC-1 Cl(
239 ted by translation of preformed mRNA through protein kinase C (PKC)-induced recruitment of mRNA to po
240 The angiotensin AT1 receptor expression and protein kinase C (PKC)-mediated NMDA receptor phosphoryl
241 sis and is inhibited in vitro and in vivo by protein kinase C (PKC)-mediated phosphorylation at CaS(T
242 uit Disc large homolog 1 (Dlgh1) and exclude protein kinase C (PKC)-theta from immunological synapses
250 nhancer factor 2C (MEF2c) expression via the protein kinase C (PKC)/histone deacetylase 5-mediated pa
252 sphatase 2A (PP2A) and augmented activity of protein kinase C (PKC)alpha/beta, which was dissociated
253 IL-1R-associated kinase (IRAK)1, MyD88, and protein kinase C (PKC)epsilon to the downstream TLR-sign
254 statin-1, a relatively specific activator of protein kinase C (PKC)epsilon, (also of PKCalpha) on imp
256 ed proteins from public databases identified protein kinase C (PKC)zeta as a TRIM32-associated protei
258 dependent signals control phosphorylation of protein kinase C (Pkc1), which plays an essential role i
260 hat distinct isoforms of persistently active protein kinase Cs (PKMs) maintain distinct forms of long
261 Da regulatory light chains (LC20) but not of protein kinase C-potentiated inhibitory protein for myos
263 enzymatic activity of PLCdelta1, leading to protein kinase C/protein kinase D/extracellular signal-r
265 ule for diacylglycerol and phorbol esters in protein kinase C, Ras guanine nucleotide releasing prote
266 osphorylation of Pah1 by protein kinase A or protein kinase C reduced its subsequent phosphorylation
268 METHODS AND ET-1, through activation of PKC (protein kinase C), reduced surface beta1 abundance and t
269 titively with diacylglycerol, the endogenous protein kinase C regulator, and plant-derived phorbol es
270 ation end products, L-type calcium channels, protein kinase C, Rho-kinase, actin polymerization, and
272 malization of KCC2 function was dependent on protein kinase C signaling and phosphorylation of KCC2 a
273 ligin-3 in response to synaptic activity and protein kinase C signaling resulting in reduced synapse
276 d GPCR-kinase interacting protein-1-mediated protein kinase C-stimulated phosphorylation of MaxiKbeta
277 e HIF-alpha network, we identified the major protein kinase C substrate MARCKS (myristoylated alanine
278 l-9 on T cells following PMA stimulation via protein kinase C suggests persistent TCR stimulation as
279 ly, T cell receptor (TCR) signaling molecule protein kinase C theta (PKC-theta)-mediated phosphorylat
283 ical model demonstrated that neuroendocrine, protein kinase C-theta, and triggering receptor expresse
284 In infected cells, wild-type virus recruits protein kinase C to the nuclear membrane and triggers it
285 amma receptors, signaling via Syk, PI3K, and protein kinase C to trigger the production of toxic reac
287 The functions of phospholipase Cbeta and protein kinase C were required for OXTR-induced augmenta
288 oprostanes, NOX2 (NADPH oxidase 2), and PKC (protein kinase C) were measured in obese mice and compar
291 downstream signaling involves activation of protein kinase C, which phosphorylates and activates wit
292 These data indicate that Ang II activates protein kinase C, which stimulates KV 1.5 channel degrad
295 itro and insulin resistance in vivo activate protein kinase C zeta (PKCzeta) in pancreatic islets and
297 zyme A reductase, phospholipase A2 receptor, protein kinase C zeta type, tubulin beta-4B class IVb, v
298 neural progenitors was dependent on atypical protein kinase C zeta, a mediator of stem cell polarity,
299 n-induced phosphoinositide 3-kinase (PI3-K), protein kinase C-zeta (PKC-zeta), extracellular signal-r
300 that hypusine biosynthesis was downstream of protein kinase C-zeta and was required for c-Myc-induced